Copyright
©The Author(s) 2022.
World J Clin Oncol. Jun 24, 2022; 13(6): 505-519
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.505
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.505
Figure 1 Diagram of the administration schedule for the determination of cell viability or cell sensitivity to chemotherapy.
PX: Paclitaxel; NIC: Nicotine.
- Citation: Español A, Sanchez Y, Salem A, Obregon J, Sales ME. Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells. World J Clin Oncol 2022; 13(6): 505-519
- URL: https://www.wjgnet.com/2218-4333/full/v13/i6/505.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i6.505